Abzena Invests $5M to Boost Bioconjugate Development & Manufacturing
Breaking News Aims to increase efficiencies at its Bristol, PA site in response to customer demand for bioconjugate development and cGMP manufacturing. 03.27.24 Abzena, an end-to-end integrated CDMO, has announced a $5 million expansion of its Bristol, PA …